Connect
MJA
MJA

STORM, a new dimension for mammography screening

Nehmat Houssami
Med J Aust 2013; 199 (5): 308-309. || doi: 10.5694/mja13.10638
Published online: 2 September 2013

Evidence of improved detection using integrated 2D and 3D mammography provides opportunity for Australia to lead screening trials

The STORM (Screening with Tomosynthesis or Standard Mammography) trial, from a team of Italian and Australian researchers, reports the world’s first completed population breast screening trial of integrated 2-dimensional (2D) and 3-dimensional (3D) mammography.1 Using breast tomosynthesis, a pseudo-3D derivative of digital mammography, in combination with 2D mammography, STORM researchers found that breast cancer detection was significantly increased when screen-reading was performed using integrated 2D and 3D mammography compared with 2D mammography alone (Box).1 The trial also showed that this screening method could significantly reduce false-positive results (Box). These data provide evidence that integrated 2D and 3D mammography would enhance breast screening performance measures, and are consistent with the interim findings of another population screening study conducted in Oslo, Norway, using the same mammographic technology.2

  • Nehmat Houssami

  • Screening and Diagnostic Test Evaluation Program, Sydney School of Public Health, University of Sydney, Sydney, NSW.

Correspondence: nehmath@med.usyd.edu.au

Acknowledgements: 

I receive research support through a National Breast Cancer Foundation Practitioner Fellowship.

Competing interests:

The STORM trial was conducted in Italy with support from Hologic (Hologic, United States, and Technologic, Italy) through provision of tomosynthesis technology. I was the scientific director of the trial.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.